Chemicals M&A To See Upturn in 2026 (Chemical Week Feb 2 – Feb 9, 2026)Jonathan Choi2026-02-23T22:49:38+00:00February 23rd, 2026|Featured, Our Publications|
The Good, The Bad, and the Ugly (ICIS Chemical Business Jan 30 – Feb 5, 2026)Jonathan Choi2026-02-18T14:30:15+00:00February 18th, 2026|Featured, Our Publications|
Signs of Revival in Chemical M&A (ICIS Chemical Business Jan 23 – Jan 29, 2026)Jonathan Choi2026-02-18T14:28:50+00:00February 18th, 2026|Featured, Our Publications|
Financing Markets Mixed, Equities Lag (ICIS Chemical Business Nov 27 – Dec 4, 2025)Jonathan Choi2025-12-19T16:33:57+00:00December 4th, 2025|Featured, Our Publications|
Chemical M&A Mixed, Sideways (ICIS Chemical Business Nov 21 – Nov 27, 2025)Jonathan Choi2025-12-19T16:21:22+00:00November 27th, 2025|Featured, Our Publications|
Navigating Divergent Currents – Biopharma Review and Outlook (Pharmaceutical Executive, August 2025)Jonathan Choi2025-10-08T17:59:06+00:00August 31st, 2025|Featured, Our Publications|
The Chemical M&A Market Treads Water (August 12, 2025)Jonathan Choi2025-08-12T22:41:59+00:00August 12th, 2025|Featured, Our Publications|
Pharma and Biotech: M&A Review and OutlookJonathan Choi2025-08-12T15:03:30+00:00August 12th, 2025|Featured, Our Publications|
Peter Young Receives the Foreign Policy Association MedalJonathan Choi2025-06-27T22:11:13+00:00June 27th, 2025|Featured, Our Publications|
Chemical Stock Market and Funding in the First Quarter 2025 and BeyondJonathan Choi2025-06-11T16:44:18+00:00June 11th, 2025|Featured, Our Publications|
